📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). (2023)

First Author: Patel J

Attributed to: Stratified interventions in ARDS (EMINENT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.90737

Publication URI: https://www.repository.cam.ac.uk/handle/1810/343326

Type: Journal Article/Review